Search Results - Li YN

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Chronic Inflammation Index-Based Tumor Subsite Classification Correlated with Chemotherapy Benefit and Survival Outcomes in Stage II-III Colorectal Cancer by Lu Y, Ye QY, Mei O, Li YN, Peng Y, Ying HQ, Cheng XX

    Published in Journal of Inflammation Research (2025-05-01)
    Get full text
    Article


  2. 2

    Comparing Remimazolam and Propofol for Postoperative Anesthesia Satisfaction in Outpatient Gynecological Surgery: A Randomized Clinical Trial by Wang XL, Dai LL, Li YN, Zhang JW, Qu MC, Zhou YY, Xing N

    Published in Drug Design, Development and Therapy (2024-10-01)
    Get full text
    Article


  3. 3

    Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Tran... by Luo MC, Wu JY, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML

    Published in Journal of Hepatocellular Carcinoma (2023-10-01)
    Get full text
    Article


  4. 4

    Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastase... by Liu DY, Li YN, Wu JY, Zeng ZX, Fu YK, Li H, Ou XY, Zhang ZB, Wang SJ, Wu JY, Yan ML

    Published in Journal of Hepatocellular Carcinoma (2024-11-01)
    Get full text
    Article


  5. 5

    Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors by Wei SM, Zeng ZX, Pan RJ, Wu JY, Wu JY, Luo MC, Li YN, Li H, Liu DY, Ou XY, Zhang ZB, Zhou JY, Li B, Zhuang SW, Yan ML

    Published in Journal of Inflammation Research (2025-06-01)
    Get full text
    Article


Search Tools: